Jason S. Carter - Nov 18, 2024 Form 4 Insider Report for Vera Therapeutics, Inc. (VERA)

Role: Chief Legal Officer
Signature: /s/ Joseph R. Young, Attorney-in-Fact
Stock symbol: VERA
Transactions as of: Nov 18, 2024
Transactions value $: $0
Form type: 4
Date filed: 11/20/2024, 04:07 PM

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VERA	Class A Common Stock	Award	$0	+53K		$0.00	53K	Nov 18, 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VERA	Stock Option (right to buy)	Award	$0	+108K		$0.00	108K	Nov 18, 2024	Class A Common Stock	108K	$44.81	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the number of shares of Class A Common Stock underlying the restricted stock units ("RSUs") under the Issuer's 2024 Inducement Plan. One-fourth of the RSUs vest on each February 20, May 20, August 20 and November 20 following the vesting commencement date of November 18, 2024, subject to the Reporting Person's continuous service through each vesting date.
F2	1/4 of the shares subject to the option vest on November 18, 2025, and 1/48 of the shares vest monthly thereafter, subject to continuous service of the Reporting Person through each vesting date.